A Shot In The Arm To Fight Skin Cancer
Therapeutic cancer vaccines are uniquely designed to stimulate the body's own defenses -- the immune system -- to find and fight cancer cells. The vaccine is designed to treat existing cancer rather than prevent it from developing. Sanofi Pasteur, the vaccines division of sanofi-aventis Group, has invested more than five years of work to develop this vaccine regimen and bring it to clinical trials.
About Sanofi Aventis
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, provided more than 1.6 billion doses of vaccine in 2007, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, sanofi pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR1 million in research and development. For more information, please visit: http://www.sanofipasteur.com.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:
Pasteur, Sanofi. "A Shot In The Arm To Fight Skin Cancer." Medical News Today. MediLexicon, Intl., 16 Jan. 2009. Web.
25 Jun. 2017. <http://www.medicalnewstoday.com/releases/135646.php>
Pasteur, S. (2009, January 16). "A Shot In The Arm To Fight Skin Cancer." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
Contact our news editors
For any corrections of factual information, or to contact our editorial team, please see our contact page.
Copyright Medical News Today: Excluding email/sharing services explicitly offered on this website, material published on Medical News Today may not be reproduced, or distributed without the prior written permission of Medilexicon International Ltd. Please contact us for further details.